Election 2026
Independent, source-first accountability
Issue record
What each candidate says on this issue, and what their own official record shows.
Campaign positions
Her campaign says making health care more affordable and accessible for families, seniors and people in rural Maine is one of her priorities. In a July op-ed she backs the INSULIN Act, which would cap insulin at $35 a month for people with private or employer insurance.
His campaign's priorities are to pass Medicare for All and to lower the cost of prescription drugs.
Evidence timeline
official action
She sponsored the 2026 bill; the proposed expansion has not become law.
In the October 13 debate, Collins said she had introduced a bill to expand Medicare coverage for medical nutrition therapy. Collins sponsored S. 3934, the Medical Nutrition Therapy Act of 2026, introduced February 26. It would expand Medicare nutrition therapy services. It was referred to Senate Finance; the October 22 record lists no law. Limit: This verifies the bill she introduced. It does not show that the proposed coverage expansion is in force.
official action
Her home-health proposal includes screening and inspection measures; it is not law.
In the October 13 debate, Collins said she had introduced a bill to improve Medicare fraud screening and on-site inspections. Collins sponsored S. 5250, introduced August 5, 2026. It proposes more home-health agency screening, inspections and funding for unannounced visits. The October 22 record lists no law. Limit: This verifies her home-health proposal, not savings, increased hospital payments or an enacted reform.
official action
His bill became law before the board voted to keep the Caribou and Machias homes open.
In the October 13 debate, Jackson cited his work to keep the Caribou veterans home open. Jackson sponsored L.D. 2001, signed March 31, 2022, as Public Law 2021, chapter 528. The governor’s April 4 announcement records the board’s subsequent vote to keep Caribou and Machias open and credits Jackson’s legislation, legislative support and the governor’s funding. Limit: This documents a shared role in the 2022 decision, not sole credit or the facilities’ current finances.
official action
She was the first cosponsor of the 2026 INSULIN Act, and the Senate health committee approved it 17 to 5 in July; it has not passed the Senate.
In a July op-ed she says she joined three Senate colleagues this spring to introduce the INSULIN Act, and that it passed the Senate health committee by a bipartisan vote of 17 to 5. S. 4189, the INSULIN Act of 2026, was introduced on March 25, 2026 by Jeanne Shaheen for herself, Collins, Raphael Warnock and John Kennedy, with eight more original cosponsors; Collins is named first. The Health, Education, Labor and Pensions Committee ordered it reported with a substitute on July 22, 2026; the committee's own record of that session lists it as agreed to by roll call vote, 17 to 5. It was placed on the Senate calendar on August 7. The reported text keeps a cap of $35 per 30-day supply for private and employer coverage. It has not passed the Senate. Limit: The introduction, the committee's approval and its 17-to-5 tally are on the record, and Congress.gov lists Shaheen as the sponsor, which is what "joined three Senate colleagues" says. The committee's page does not list each senator's vote, but the tally shows both parties voted yes: neither party has 17 seats on the committee (the Senate's roster lists 12 Republicans and 11 Democrats). A bill reported from committee is not law.
official action
Collins originally cosponsored a bill to support rural medical residencies, including obstetrics; it remains a proposal.
Collins said she introduced bipartisan legislation for rural medical residencies. She originally cosponsored S.5232 on August 4, 2026. It would authorize grants for rural residencies, including family medicine and obstetrics. Limit: The bill remains in committee; it has not become law.
official action
The 2026 funding law she voted for sets the program at $200 million, its largest yearly amount; the record does not show who wrote that figure.
In a July op-ed she says that as Appropriations chair she secured a record $200 million for the Special Diabetes Program in this year's funding legislation. Section 6402 of the Consolidated Appropriations Act, 2026, Public Law 119-75, signed February 3, 2026, sets the Special Diabetes Program for Type 1 diabetes at $200,000,000 for fiscal year 2026, against $159,228,188 for 2025 and $155,619,196 for 2024. The program's schedule in the U.S. Code has no year before 2024 above $150,000,000, so $200 million is the largest annual amount it has had. She voted Yea when the Senate passed the act 71 to 29 on January 30 (Roll Call 20). Her own reauthorization bill, S. 2211, introduced in July 2025, had asked for $160,000,000 a year. Limit: The amount, the year and the word record are borne out by the law. "I secured" is a claim about her part in writing it, which no roll call settles: she chaired the committee that produced the year's spending bills and voted for the package, and the enacted amount is larger than her own bill asked for, but the health extensions in it are authorizing provisions that other committees also shaped.
official action
Her 2025 bill stalled in committee, but both of its changes became law inside the 2026 funding act, with funding starting a year later than she proposed.
Her campaign lists the Lifespan Respite Care Reauthorization Act, signed in 2026, among the legislation she has authored or co-authored. She introduced S. 830, the Lifespan Respite Care Reauthorization Act of 2025, with Tammy Baldwin on March 4, 2025. The bill went no further than committee, but both of its operative changes became law as section 6506 of the Consolidated Appropriations Act, 2026, signed February 3, 2026: the definition of a family caregiver changes from an unpaid adult to an unpaid individual, in the same words, and the program's funding runs through 2030, for fiscal years 2026 through 2030 rather than the 2025 through 2030 her bill proposed. Limit: What became law is her bill's text inside a larger act, not the stand-alone Act the campaign names, and its funding starts a year later than she proposed. It is the same provision, so the claim holds in substance. The dollar amounts the program receives are set elsewhere and were not compared.
official action
Collins voted for the 2026 spending law with a reported $415 million NIH funding increase; this does not assign her sole credit.
Collins said medical-research funding increased $415 million instead of being cut. She voted for the 2026 spending law. Appropriators reported a $415 million increase for NIH, including ARPA-H. Limit: This checks that funding package, not all research spending or sole credit.
official action
She voted for H.R.5371 on November 10, 2025. The law, signed November 12, appropriated $8.2 billion for WIC for fiscal 2026.
Collins said she supported WIC, the nutrition program for women, infants and children. She voted for H.R.5371 on November 10, 2025. The law, signed November 12, appropriated $8.2 billion for WIC for fiscal 2026. Limit: Her vote covered the whole bill. This does not assess every safety-net program or the funding’s results.
official action
She voted to start debate and against final passage; the $50 billion fund was in the bill before her amendment to enlarge it, which failed, so the record does not show she wrote it.
In both debates she said she voted against the One Big Beautiful Bill because of its Medicaid cuts, but voted to let it reach the floor, and that this let her author its $50 billion rural health fund. On October 6 she said she had proposed paying for the fund by raising taxes on top earners. She voted Yea on the motion to take up H.R. 1 on June 28, 2025, which carried 51 to 49, and Nay on passage on July 1, which carried 50 to 50 on the Vice President's tie-breaking vote. The law, Public Law 119-21, creates the Rural Health Transformation Program with $10 billion a year from 2026 to 2030. The fund was already in the Senate's substitute text when she offered an amendment to raise its first two years to $22.5 billion each, paid for with a 39.6 percent tax rate on income over $25 million. The amendment was ruled out of order, and a motion to waive the rule failed 22 to 78, with her Yea. Limit: Her two votes on the bill are on the record and match what she said. Who wrote the fund is not: it was in the text before her amendment, which failed. The captions have her putting the tax on people making over $250,000 a year; her amendment's rate started at $25 million. The $190 million she said Maine got in the first year was not checked; the federal agency's site refused our script.
campaign position
He sponsored two 2019 prescription drug laws, one creating a drug affordability board, and a 2021 bill that was vetoed; the record does not show whether prices fell.
His campaign says that in the legislature he fought hard to successfully lower prescription drug prices. In 2019, as Senate President, he sponsored two prescription-drug bills that became law: LD 1499, which created the Maine Prescription Drug Affordability Board, and LD 1272, An Act To Increase Access to Low-cost Prescription Drugs. The Senate accepted the committee's majority report on each 35 to 0 on June 11, 2019, with his Yea vote (Roll Calls 264 and 263), and later enacted both without a recorded vote; the House enacted them 126 to 15 and 138 to 3. Both were signed on June 24, 2019, as Public Law 2019, chapters 471 and 472. In 2021 he sponsored LD 1117, An Act To Prevent Excessive Prices for Prescription Drugs. Both chambers passed it, the Governor vetoed it, and the Senate's override vote, 20 to 14 with his Yea, fell short of the 23 votes needed (Roll Call 506). In 2024 his LD 2114 became a resolve, Resolve 2024, chapter 177, directing the Superintendent of Insurance to collect data on how insurers cover generic drugs and biosimilars and to report to the Legislature. Why there is no verdict: The claim is that prices came down, and no official source read for this desk publishes that figure. The laws set up a board and a program; the record shows them enacted, not what they changed at the pharmacy counter. The next test is the Prescription Drug Affordability Board's annual reports to the Legislature. Limit: Sponsorship, his votes and enactment are on the record; the outcome the sentence claims is not.
official action
Jackson cosponsored Maine’s $35 insulin cap and later sponsored a discounted-pen proposal that died; his intended bill and $30 figure remain unverified.
Jackson said he helped sponsor a bill to lower insulin to $30. He cosponsored LD2096, enacted March 18, 2020, capping covered insulin cost-sharing at $35 per prescription for a 30-day supply from 2021. He also sponsored LD1793 in 2023 to buy discounted insulin pens; it died March 27, 2024. Limit: These records show support for lower insulin costs. They do not identify which bill he meant or verify the captioned $30 figure.
official action
Her 2017 bill with Claire McCaskill became, in changed form, one section of a larger FDA law she voted for that year.
In the October 8 debate she said that as head of the Senate Aging Committee she looked into high drug prices, found barriers keeping lower-priced generics off the market, and wrote the law that speeds up approval of generic drugs. On October 6 she said she had worked to speed approval of lower-cost generics. In February 2017 she sponsored S. 297, with Claire McCaskill, to have the FDA put generic drugs with little or no competition first in line for review and act on them within 150 days. A version of that section became law as section 801 of the FDA Reauthorization Act, Public Law 115-52, signed August 18, 2017: the FDA must prioritize generics of drugs with few competitors and act within 8 months, and its line letting the FDA speed up inspections of their plants is word for word from her bill. She voted for the act, which passed the Senate 94 to 1 on August 3, 2017. That day she told the Senate it carried provisions based on her bill with McCaskill, which grew out of the Aging Committee's investigation of price spikes, adopted as her amendment in committee. Limit: Her bill became part of a larger law, not all of it, and the version that passed gives the FDA 8 months to act, not her bill's 150 days. The committee's record of her amendment was not read; the floor statement is her own account.
See something wrong or incomplete? Report it for review.
Collins for Senator · Reviewed Sep 23, 2026
Campaign-controlled source and the fullest statement of the record she runs on: workforce, health care, Alzheimer's, diabetes, Social Security and congressionally directed spending.
candidate statement
For: Susan M. Collins: campaign position
Collins for Senator · Published Jul 29, 2026 · Reviewed Sep 23, 2026
Her op-ed, republished on the campaign site on July 29, 2026. Used for the INSULIN Act and the Special Diabetes Program figure.
candidate statement
For: Susan M. Collins: campaign position; Susan M. Collins: Matches stated record claim
Troy Jackson for Maine · Reviewed Sep 23, 2026
Campaign-controlled source: eleven priorities, listed without detail.
candidate statement
For: Troy D. Jackson: campaign position
WABI / WAGM · Published Oct 13, 2026 · Reviewed Oct 22, 2026
39:11. Paraphrase of saved native English captions; no second transcript compared.
candidate statement
For: Susan M. Collins: Matches stated record claim
Congress.gov / U.S. Government Publishing Office · Published Feb 26, 2026 · Reviewed Oct 22, 2026
Collins sponsor confirmed by Congress.gov API; introduced text read from GovInfo. No law listed at the October 22 readback.
official legislative record
For: Susan M. Collins: Matches stated record claim
WABI / WAGM · Published Oct 13, 2026 · Reviewed Oct 22, 2026
41:25; paraphrase of saved native English captions; no second transcript compared.
candidate statement
For: Susan M. Collins: Matches stated record claim
Congress.gov / U.S. Government Publishing Office · Published Aug 5, 2026 · Reviewed Oct 22, 2026
Primary record reviewed October 22, 2026 for this debate comparison.
official legislative record
For: Susan M. Collins: Matches stated record claim
WABI / WAGM · Published Oct 13, 2026 · Reviewed Oct 22, 2026
32:28; paraphrase of saved native English captions; no second transcript compared.
candidate statement
For: Troy D. Jackson: Matches stated direction
Maine Legislature · Published Mar 31, 2022 · Reviewed Oct 22, 2026
Primary record reviewed October 22, 2026 for this debate comparison.
official legislative record
For: Troy D. Jackson: Matches stated direction
Office of the Governor of Maine · Published Apr 4, 2022 · Reviewed Oct 22, 2026
Primary record reviewed October 22, 2026 for this debate comparison.
official office record
For: Troy D. Jackson: Matches stated direction
Congress.gov · Reviewed Sep 23, 2026
Sponsor Jeanne Shaheen; Collins first of eleven original cosponsors. Ordered reported by the HELP Committee with a substitute on July 22, 2026; placed on the calendar August 7. The reported text (GovInfo BILLS-119s4189rs) keeps a $35 cap per 30-day supply.
official legislative record
For: Susan M. Collins: Matches stated record claim
Senate Committee on Health, Education, Labor and Pensions · Published Jul 22, 2026 · Reviewed Sep 23, 2026
The committee's own page for the July 22, 2026 executive session lists "S. 4189, INSULIN Act of 2026 (Agreed to by Roll Call Vote, 17-5)", a manager's amendment agreed to by voice vote, and a Baldwin amendment agreed to 12 to 10. It does not list how each senator voted.
official legislative record
For: Susan M. Collins: Matches stated record claim
United States Senate · Reviewed Sep 23, 2026
The Senate's membership file, read September 23, 2026: 23 members, 12 Republicans and 11 Democrats. A 17-vote yes needs members of both parties under any split in which neither party holds 17 seats.
official office record
For: Susan M. Collins: Matches stated record claim
WABI · Published Oct 13, 2026 · Reviewed Oct 28, 2026
Paraphrase from the dated debate; timestamp links to the statement.
candidate statement
For: Susan M. Collins: Matches stated record claim
U.S. Congress · Published Aug 4, 2026 · Reviewed Oct 28, 2026
Collins is an original cosponsor; the bill remains a proposal.
official legislative record
For: Susan M. Collins: Matches stated record claim
U.S. Government Publishing Office · Published Aug 4, 2026 · Reviewed Oct 28, 2026
Authorizes rural residency grants, including family medicine and obstetrics.
official legislative record
For: Susan M. Collins: Matches stated record claim
U.S. Congress · Published Aug 4, 2026 · Reviewed Oct 28, 2026
Smith sponsored the bill; Collins joined as an original cosponsor August 4.
official legislative record
For: Susan M. Collins: Matches stated record claim
Congress.gov · Reviewed Sep 23, 2026
Signed February 3, 2026. The enrolled text (GovInfo BILLS-119hr7148enr) was read for sections 6402, the special diabetes programs, and 6506, lifespan respite care.
official legislative record
For: Susan M. Collins: Matches stated record claim
U.S. Government Publishing Office · Reviewed Sep 23, 2026
The program's appropriation schedule from its start: $30,000,000 transferred a year for 1998 to 2002, plus $70,000,000 appropriated a year for 2001 and 2002, $100,000,000 for 2003, $150,000,000 a year for 2004 to 2023, and short-term amounts after.
official legislative record
For: Susan M. Collins: Matches stated record claim
U.S. Government Publishing Office · Reviewed Sep 23, 2026
Congressional Record of January 30, 2026. Passed 71 to 29. Read with the shared collector.
official legislative record
U.S. Government Publishing Office · Published Jan 30, 2026 · Reviewed Oct 27, 2026
Collins Yea; H.R.7148 passed the Senate 71–29.
official legislative record
For: Susan M. Collins: Matches stated record claim; Susan M. Collins: Matches stated direction
Congress.gov · Reviewed Sep 23, 2026
Sponsor Collins, with Jeanne Shaheen; introduced July 8, 2025 and referred to committee. Proposed $160,000,000 for each of fiscal years 2026 and 2027.
official legislative record
For: Susan M. Collins: Matches stated record claim
Collins for Senator · Reviewed Sep 23, 2026
Campaign-controlled source. Names her committees, her bid for a sixth term, legislation she says she authored or co-authored, and her roll-call streak.
candidate statement
For: Susan M. Collins: Matches stated record claim
Congress.gov · Reviewed Sep 23, 2026
Sponsor Collins, with Tammy Baldwin; introduced March 4, 2025 and referred to committee. Its two operative changes were compared with section 6506 of Public Law 119-75.
official legislative record
For: Susan M. Collins: Matches stated record claim
Maine Public · Published Oct 15, 2026 · Reviewed Oct 27, 2026
Paraphrase from saved native captions; the exact proposed-cut percentage is not assessed.
candidate statement
For: Susan M. Collins: Matches stated direction
U.S. Government Publishing Office · Published Jan 22, 2026 · Reviewed Oct 27, 2026
Appropriators report a $415 million NIH increase. The enacted NIH/ARPA-H funding text matches this bill block.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Government Publishing Office · Published Feb 3, 2026 · Reviewed Oct 27, 2026
Enacted February 3, 2026. Division B funds NIH and ARPA-H; the reported increase concerns this grouping, not all medical research.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Senate Committee on Appropriations · Reviewed Oct 27, 2026
Reports $48.7 billion for NIH including ARPA-H, $415 million above FY2025. Complete summary read; the figure is attributed rather than independently recalculated from every prior-year account.
official legislative record
For: Susan M. Collins: Matches stated direction
Maine Public / NEWS CENTER Maine / Portland Press Herald · Published Oct 15, 2026 · Reviewed Nov 2, 2026
Paraphrase from one saved native English-caption copy, about 26:01–26:26. The surrounding exchange was checked; caption cue timings locate the passage, not exact speech boundaries.
candidate statement
For: Susan M. Collins: Matches stated record claim
U.S. Senate · Published Nov 10, 2025 · Reviewed Nov 2, 2026
Final passage carried 60–40; Collins voted Yea. Her vote covered the complete bill.
official legislative record
For: Susan M. Collins: Matches stated record claim
U.S. Government Publishing Office · Published Nov 12, 2025 · Reviewed Nov 2, 2026
Signed November 12, 2025. Division B, Title IV, 139 Stat. 534 appropriates $8.2 billion for fiscal 2026 WIC. The total includes a $150 million reserve available through September 30, 2027; an appropriation is not spending or outcomes.
official legislative record
For: Susan M. Collins: Matches stated record claim
CBS 13 News (WGME) · Published Oct 6, 2026 · Reviewed Oct 10, 2026
6:59-8:13. Described from the host's YouTube captions; no second transcript was found, so the words are not quoted.
candidate statement
For: Susan M. Collins: Matches stated direction
WMTW-TV · Published Oct 8, 2026 · Reviewed Oct 10, 2026
26:54-28:32. Described from the host's YouTube captions; no second transcript was found, so the words are not quoted.
candidate statement
For: Susan M. Collins: Matches stated direction
U.S. Senate · Reviewed Oct 10, 2026
June 28, 2025. Agreed to 51 to 49; Collins Yea.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Government Publishing Office · Reviewed Sep 23, 2026
Printed in the Record of the June 30, 2025 legislative day; Congress.gov dates the vote July 1, 2025. 50 to 50, with the Vice President voting to pass it. Read with the shared collector.
official legislative record
For: Susan M. Collins: Matches stated direction
Congress.gov · Reviewed Sep 23, 2026
The 2025 reconciliation act; became law July 4, 2025.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Government Publishing Office · Reviewed Oct 10, 2026
Section 71401 creates the Rural Health Transformation Program, with $10,000,000,000 for each fiscal year from 2026 to 2030.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Government Publishing Office · Published Jun 30, 2025 · Reviewed Oct 10, 2026
Collins's amendment to SA 2360, the substitute Thune offered for Graham. It adds a 39.6 percent rate on taxable income over $25 million ($50 million for joint filers) and raises the rural fund's first two years from $10 billion to $22.5 billion each.
official legislative record
For: Susan M. Collins: Matches stated direction
Congress.gov · Reviewed Oct 10, 2026
Sponsored by Collins. Ruled out of order by the chair on July 1, 2025.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Senate · Reviewed Oct 10, 2026
July 1, 2025. Rejected 22 to 78, with three-fifths needed; Collins Yea.
official legislative record
For: Susan M. Collins: Matches stated direction
Troy Jackson for Maine · Reviewed Sep 23, 2026
Campaign-controlled source and his fullest statement of his legislative record. It says he "championed and passed some of the strongest reproductive health protections anywhere in the country".
candidate statement
For: Troy D. Jackson: record does not settle this
Maine Legislature · Reviewed Sep 23, 2026
Sponsored by President Troy Jackson. House enactment 126 to 15 (Roll Call 244); Senate enactment without a recorded vote, after the Senate accepted the committee's majority report 35 to 0 on Roll Call 264; signed June 24, 2019, Public Law 2019, chapter 471.
official legislative record
For: Troy D. Jackson: record does not settle this
Maine Legislature · Reviewed Sep 23, 2026
Sponsored by President Troy Jackson. House enactment 138 to 3 (Roll Call 243); Senate enactment without a recorded vote, after the Senate accepted the committee's majority report 35 to 0 on Roll Call 263; signed June 24, 2019, Public Law 2019, chapter 472.
official legislative record
For: Troy D. Jackson: record does not settle this
Maine Legislature · Reviewed Sep 23, 2026
June 11, 2019. Prevailed 35 to 0; Jackson of Aroostook recorded Y. The bill's roll-call list shows this as the only Senate roll call on LD 1499.
official legislative record
For: Troy D. Jackson: record does not settle this
Maine Legislature · Reviewed Sep 23, 2026
June 11, 2019. Prevailed 35 to 0; Jackson of Aroostook recorded Y. The bill's roll-call list shows this as the only Senate roll call on LD 1272.
official legislative record
For: Troy D. Jackson: record does not settle this
Maine State Law and Legislative Reference Library · Reviewed Sep 23, 2026
The Legislature's law library lists Troy Dale Jackson of Allagash, Democrat, as President for 2019-2024, followed by Matthea Daughtry from 2025. Its Legislature column for his row reads 128th - 131st, which does not match those years (the 129th Legislature began in December 2018); the years are what this desk relies on. The Legislature's bill summary pages show a legislator's latest title, not the title when a bill was filed, so they cannot date his presidency.
official office record
For: Troy D. Jackson: record does not settle this
Maine Legislature · Reviewed Sep 23, 2026
Sponsored by President Troy Jackson. Enacted by the House and the Senate on June 17, 2021 (actions page, dockets.asp?ID=280079688); vetoed; on July 19, 2021 the Senate voted 20 to 14 to override, short of two-thirds, and the veto was sustained.
official legislative record
For: Troy D. Jackson: record does not settle this
Maine Legislature · Reviewed Sep 23, 2026
July 19, 2021. 23 yeas required; failed 20 to 14. Jackson of Aroostook recorded Y.
official legislative record
For: Troy D. Jackson: record does not settle this
Maine Legislature · Reviewed Sep 23, 2026
Sponsored by President Troy Jackson. Finally passed by both chambers without a roll call; signed April 22, 2024 as Resolve 2024, chapter 177.
official legislative record
For: Troy D. Jackson: record does not settle this
Maine Legislature · Reviewed Sep 23, 2026
Directs the Superintendent of Insurance to request data from health insurers on how they cover generic drugs and biosimilars, and to report to the Legislature by February 15, 2025. Read as a PDF (sha256 42b1bc9b...5b16).
official legislative record
For: Troy D. Jackson: record does not settle this
WABI · Published Oct 13, 2026 · Reviewed Oct 28, 2026
Paraphrase from the dated debate; timestamp links to the statement.
candidate statement
For: Troy D. Jackson: Matches stated direction
Maine Legislature · Published Feb 4, 2020 · Reviewed Oct 29, 2026
Cover lists President Jackson of Aroostook as cosponsor; introduced cap differs from final amended cap.
official legislative record
For: Troy D. Jackson: Matches stated direction
Maine Legislature · Published Feb 4, 2020 · Reviewed Oct 29, 2026
Jackson is a cosponsor, not the first-named sponsor. Does not identify the bill meant in his 2026 debate answer.
official legislative record
For: Troy D. Jackson: Matches stated direction
Maine Legislature · Published Mar 18, 2020 · Reviewed Oct 29, 2026
Enacted cap $35 per prescription per 30-day supply, for covered policies issued or renewed from January 1, 2021; not a universal cash price.
official legislative record
For: Troy D. Jackson: Matches stated direction
Maine Legislature · Published Mar 18, 2020 · Reviewed Oct 29, 2026
Became Public Law chapter 666 on March 18, 2020.
official legislative record
For: Troy D. Jackson: Matches stated direction
Maine Legislature · Published Apr 25, 2023 · Reviewed Oct 28, 2026
Jackson sponsored a proposed state contract to buy discounted insulin pens.
official legislative record
For: Troy D. Jackson: Matches stated direction
Maine Legislature · Published Mar 27, 2024 · Reviewed Oct 28, 2026
The proposal was placed in legislative files as dead March 27, 2024.
official legislative record
For: Troy D. Jackson: Matches stated direction
WMTW-TV · Published Oct 8, 2026 · Reviewed Oct 10, 2026
29:25-29:58. Described from the host's YouTube captions; no second transcript was found, so the words are not quoted.
candidate statement
For: Susan M. Collins: Matches stated direction
CBS 13 News (WGME) · Published Oct 6, 2026 · Reviewed Oct 10, 2026
4:50-5:02. Described from the host's YouTube captions; no second transcript was found, so the words are not quoted.
candidate statement
For: Susan M. Collins: Matches stated direction
Congress.gov · Reviewed Oct 10, 2026
Introduced February 2, 2017 by Collins for herself and Claire McCaskill. Section 101 has the FDA prioritize, and act within 150 days on, generic drug applications for drugs with little or no generic competition or on the drug shortage list.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Government Publishing Office · Reviewed Oct 10, 2026
Approved August 18, 2017. Section 801 has the FDA prioritize, and act within 8 months on, generic drug applications for drugs with no more than three approved versions and no blocking patents or exclusivities, or on the drug shortage list, and lets it speed up plant inspections for them.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Senate · Reviewed Oct 10, 2026
August 3, 2017. Passed 94 to 1; Collins Yea.
official legislative record
For: Susan M. Collins: Matches stated direction
U.S. Government Publishing Office · Published Aug 3, 2017 · Reviewed Oct 10, 2026
Her floor statement before passage. She says the bill includes key provisions, based on legislation she and McCaskill sponsored after the Aging Committee's investigation of price spikes, adopted unanimously as her amendment in committee.
official legislative record
For: Susan M. Collins: Matches stated direction